-
1
-
-
84874692333
-
Muscular dystrophies
-
Mercuri E, Muntoni F. Muscular dystrophies. Lancet 2013;9869:845-60.
-
(2013)
Lancet
, vol.9869
, pp. 845-860
-
-
Mercuri, E.1
Muntoni, F.2
-
2
-
-
84857358770
-
Motor and respiratory heterogeneity in Duchenne patients: Implication for clinical trials
-
Humbertclaude V, Hamroun DF, Bezzou KF, et al. Motor and respiratory heterogeneity in Duchenne patients: implication for clinical trials. Eur J Paediatr Neurol 2012;2:149-60.
-
(2012)
Eur J Paediatr Neurol
, vol.2
, pp. 149-160
-
-
Humbertclaude, V.1
Hamroun, D.F.2
Bezzou, K.F.3
-
3
-
-
0037160782
-
The muscular dystrophies
-
Emery AE. The muscular dystrophies. Lancet 2002;9307:687-95.
-
(2002)
Lancet
, vol.9307
, pp. 687-695
-
-
Emery, A.E.1
-
4
-
-
84866252725
-
Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy
-
Bello L, Piva L, Barp A, et al. Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy. Neurology 2012;2:159-62.
-
(2012)
Neurology
, vol.2
, pp. 159-162
-
-
Bello, L.1
Piva, L.2
Barp, A.3
-
5
-
-
78751634526
-
SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy
-
Pegoraro E, Hoffman EP, Piva L, et al. SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy. Neurology 2011;3: 219-26.
-
(2011)
Neurology
, vol.3
, pp. 219-226
-
-
Pegoraro, E.1
Hoffman, E.P.2
Piva, L.3
-
6
-
-
84878937718
-
Alterations in osteopontin modify muscle size in females in both humans and mice
-
Hoffman EP, Gordish-Dressman H, McLane VD, et al. Alterations in osteopontin modify muscle size in females in both humans and mice. Med Sci Sports Exerc 2013;6:1060-8.
-
(2013)
Med Sci Sports Exerc
, vol.6
, pp. 1060-1068
-
-
Hoffman, E.P.1
Gordish-Dressman, H.2
McLane, V.D.3
-
7
-
-
67651005390
-
Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta
-
Vetrone SA, Montecino-Rodriguez E, Kudryashova E, et al. Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta. J Clin Invest 2009;6:1583-94.
-
(2009)
J Clin Invest
, vol.6
, pp. 1583-1594
-
-
Vetrone, S.A.1
Montecino-Rodriguez, E.2
Kudryashova, E.3
-
8
-
-
84878390222
-
LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy
-
Flanigan KM, Ceco E, Lamar KM, et al. LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy. Ann Neurol 2012;4: 481-8.
-
(2012)
Ann Neurol
, vol.4
, pp. 481-488
-
-
Flanigan, K.M.1
Ceco, E.2
Lamar, K.M.3
-
9
-
-
72849135317
-
Latent TGF-beta-binding protein 4 modifies muscular dystrophy in mice
-
Heydemann A, Ceco E, Lim JE, et al. Latent TGF-beta-binding protein 4 modifies muscular dystrophy in mice. J Clin Invest 2009;12:3703-12.
-
(2009)
J Clin Invest
, vol.12
, pp. 3703-3712
-
-
Heydemann, A.1
Ceco, E.2
Lim, J.E.3
-
10
-
-
72149108443
-
Diagnosis and management of Duchenne muscular dystrophy, part 1: Diagnosis, and pharmacological and psychosocial management
-
Bushby K, Finkel R, Birnkrant DJ, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 2010;1:77-93.
-
(2010)
Lancet Neurol
, vol.1
, pp. 77-93
-
-
Bushby, K.1
Finkel, R.2
Birnkrant, D.J.3
-
12
-
-
0024332294
-
Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy
-
Mendell JR, Moxley RT, Griggs RC, et al. Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. N Engl J Med 1989;24:1592-7.
-
(1989)
N Engl J Med
, vol.24
, pp. 1592-1597
-
-
Mendell, J.R.1
Moxley, R.T.2
Griggs, R.C.3
-
13
-
-
45549101581
-
Base-pair neutral homozygotes can be discriminated by calibrated high-resolution melting of small amplicons
-
Gundry CN, Dobrowolski SF, Martin YR, et al. Base-pair neutral homozygotes can be discriminated by calibrated high-resolution melting of small amplicons. Nucleic Acids Res 2008;10:3401-8.
-
(2008)
Nucleic Acids Res
, vol.10
, pp. 3401-3408
-
-
Gundry, C.N.1
Dobrowolski, S.F.2
Martin, Y.R.3
-
14
-
-
0023571274
-
Inhibition of skeletal muscle satellite cell differentiation by transforming growth factor-beta
-
Allen RE, Boxhorn LK. Inhibition of skeletal muscle satellite cell differentiation by transforming growth factor-beta. J Cell Physiol 1987;3:567-72.
-
(1987)
J Cell Physiol
, vol.3
, pp. 567-572
-
-
Allen, R.E.1
Boxhorn, L.K.2
-
15
-
-
0029153067
-
Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine
-
Bernasconi P, Torchiana E, Confalonieri P, et al. Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine. J Clin Invest 1995;2:1137-44.
-
(1995)
J Clin Invest
, vol.2
, pp. 1137-1144
-
-
Bernasconi, P.1
Torchiana, E.2
Confalonieri, P.3
-
16
-
-
1242293760
-
Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: A key event in muscle fibrogenesis
-
Li Y, Foster W, Deasy BM, et al. Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am J Pathol 2004;3:1007-19.
-
(2004)
Am J Pathol
, vol.3
, pp. 1007-1019
-
-
Li, Y.1
Foster, W.2
Deasy, B.M.3
-
17
-
-
0037191752
-
Functional improvement of dystrophic muscle by myostatin blockade
-
Bogdanovich S, Krag TO, Barton ER, et al. Functional improvement of dystrophic muscle by myostatin blockade. Nature 2002;6914:418-21.
-
(2002)
Nature
, vol.6914
, pp. 418-421
-
-
Bogdanovich, S.1
Krag, T.O.2
Barton, E.R.3
-
18
-
-
0036895736
-
Loss of myostatin attenuates severity of muscular dystrophy in mdx mice
-
Wagner KR, McPherron AC, Winik N, et al. Loss of myostatin attenuates severity of muscular dystrophy in mdx mice. Ann Neurol 2002;6:832-6.
-
(2002)
Ann Neurol
, vol.6
, pp. 832-836
-
-
Wagner, K.R.1
McPherron, A.C.2
Winik, N.3
|